DIRS.INFO The most relevant business & tech news

☆ Medtronic Blood-Pressure Device Curbs Hypertension, but Misses Top Goal in Study
▼ + stars: | 2022-11-07 | by ( Peter Loftus | ) www.wsj.com time to read: 1 min

The Medtronic device could offer a nonmedication treatment for people with blood pressure that remains high despite treatment with drugs. A Medtronic PLC medical device reduced the blood pressure of people with tough-to-treat hypertension in a closely watched study, but not significantly beyond what medications achieved. The device cut a crucial measure of blood pressure by only about two points more than the average reduction in study volunteers who didn’t get the procedure, researchers said Monday.

☆ Analysis: Wanted: an oxygen monitor reliable for all races
▼ + stars: | 2022-11-02 | by ( Nancy Lapid | ) www.reuters.com time to read: +6 min

Expert advisers to the U.S. Food and Drug Administration met virtually on Tuesday to discuss improvements in standards for pulse oximeters. Imarc Group market research firm forecast the global pulse oximeter market reaching $3.25 billion by 2027. Pulse oximeter problems "suddenly became enormous" during the pandemic, said Dr. Philip Bickler, director of the University of California, San Francisco's (UCSF) Hypoxia Research & Pulse Oximeter Test Facility. Current rules require that pulse oximeters be tested in a minimum of just 10 subjects, only two of whom must be "darkly-pigmented." While the devices are still useful, UCSF's Bickler said, doctors "should not base patient care only on pulse oximeter findings."

☆ Goldman says dividend growth stocks win in recessions – here are 10
▼ + stars: | 2022-10-31 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +3 min

Those planning for more disruption should prioritize stocks with a decent dividend yield and, perhaps more importantly, dividend growth. "In the mid-1970s, high dividend yield stocks struggled to compete with rising cash yields and lagged the S & P 500," Kostin said. Goldman recommends its recently refreshed basket of dividend growth stocks. Verizon Communications carries the highest dividend yield on the list, at 7%, with dividend growth of 2%. NXP Semiconductors and Microchip Technology have some of the fastest dividend growth for the sector, at 22% each.

☆ Wall Street set to open higher as bond yields retreat
▼ + stars: | 2022-10-24 | by ( Amruta Khandekar | ) www.reuters.com time to read: +3 min

The 10-year yield was last seen at 4.17% after hitting a 15-year high at 4.34% on Friday. The earnings reports from the four biggest U.S. companies by market capitalization could test a nascent rally on Wall Street as stocks claw their way back from the latest lows. Of the 99 companies in the S&P 500 that reported third-quarter earnings through Friday, 74.7% had beat analysts' expectations, according to Refinitiv IBES estimates. Despite the recent rebound, the index is down 21% so far in 2022, on track for its biggest decline since 2008. ET, Dow e-minis were up 144 points, or 0.46%, S&P 500 e-minis were up 14.75 points, or 0.39%, and Nasdaq 100 e-minis were up 13.25 points, or 0.12%.

☆ Medtronic to Spin Off Patient-Monitoring, Respiratory Interventions Businesses
▼ + stars: | 2022-10-24 | by ( Sabela Ojea | Peter Loftus | ) www.wsj.com time to read: 1 min

Medtronic said the separation of its businesses isn’t expected to affect the company’s dividend policy. Medtronic PLC said it is separating its patient-monitoring and respiratory intervention businesses in an effort to boost its long-term prospects. The businesses, which include pulse oximeters and ventilators, generate about $2.2 billion in annual sales, or nearly 7% of Medtronic’s overall revenue. Medtronic said the businesses, with over 8,000 employees globally, were slightly below the company’s overall performance in terms of gross margin and revenue growth.

☆ Stocks making the biggest moves in the premarket: Tesla, WeWork, Alibaba and more
▼ + stars: | 2022-10-24 | by ( Peter Schacknow | ) www.cnbc.com time to read: +2 min

Alibaba (BABA) – Alibaba tumbled 12.3% in premarket trading after the release of weaker-than-expected China GDP data. China Tech Stocks – China-based tech stocks are under pressure after President Xi secured a third leadership term, leading to speculation of a continued crackdown on the country's tech sector. ServiceNow (NOW) – ServiceNow added 2.5% in premarket trading after Guggenheim upgraded the stock to "buy" from "neutral." Medtronic added 1% in premarket trading. Williams-Sonoma fell 2.5% in premarket action.

☆ A portfolio manager beating 99% of his peers this year breaks down why the market has another 15% to 20% of downside ahead — and shares the biggest mistake investors could make once the Fed begins to
▼ + stars: | 2022-10-17 | by ( Lisa Kailai Han | ) www.businessinsider.com time to read: +7 min

Drawing from the dot-com crash, he believes the current bear market still has 15%-20% more downside. Abate also shared the biggest mistake investors could make once the Fed begins to ease once more. Today's bear market mirrors the dot-com crashPart of Abate's investment process involves drawing parallels between the current market and historical recessions. "I still think that we are in the midst of a bear market. Similarly, both bear markets were also kicked off by an "excessive period of poor allocation of investment capital," Abate said.

☆ 9 Stock Picks, Investing Strategy From Top 1% Fund Manager in 2022
▼ + stars: | 2022-10-14 | by ( Lisa Kailai Han | ) www.businessinsider.com time to read: +7 min

James Abate's fund has beaten 99% of its peers this year and over one, three, and five years. Here are his 9 standout stock picks which he says have enough pricing power to beat the bear market. He compared this dogmatic style of investing — purposely ignoring opportunities in the market — to horses running around a track with blinders on. Within energy, Abate specifically likes more gas-related names versus oil-related ones, with two standouts including Exxon Mobil (XOM) and EQT (EQT). Below is the full list of Abate's nine standout stocks along with the ticker, market capitalization, and sector for each.

☆ Harvard expert: The Twitter deal could be bad for Elon Musk—and for the rest of us
▼ + stars: | 2022-10-12 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

(Photo by Theo Wargo/WireImage)Elon Musk's controversial bid to buy Twitter could be bad news — for both the world's richest person and the general public, a Harvard expert says. "Twitter is a distraction that could keep [Musk] from what's really important," George, who has studied leadership failures over the past two decades, tells CNBC Make It. From PayPal to Tesla and SpaceX, the tech billionaire had a hand in building some of the world's most influential and valuable companies. Musk has already spent the past six months "getting distracted" by the acrimonious Twitter takeover he first proposed in April, George says. In May, Musk tried to quell concerns about him getting distracted by the Twitter deal, saying "Tesla is on my mind 24/7" during an investor call.

☆ Two-minute drill: PSA, MDT & WTW
▼ + stars: | 2022-09-26 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTwo-minute drill: PSA, MDT & WTWJeremy Bryan, Gradient Investments portfolio manager, joins 'Closing Bell: Overtime' to discuss his favorite stock picks including; Public Storage, Medtronic and Willis Towers Watson.

People walk on a street affected by the passing of Hurricane Fiona in Penuelas, Puerto Rico September 19, 2022. Baxter, which makes small bags for intravenous medication, clinical nutrition products and inhaled anesthetics in Puerto Rico, said its facilities have "sustained little to no damage" from the storm. The company took a $70 million revenue hit after Hurricane Maria in 2017, spurring it to diversify manufacturing of key products. Drugmakers with plants in Puerto Rico said they have been able to keep up production and supplies as well. Johnson & Johnson (JNJ.N) said operations were restored at all its sites in Puerto Rico by Wednesday.

☆ Cramer's lightning round: I like Boston Scientific over Medtronic
▼ + stars: | 2022-09-22 | by ( Krystal Hur | ) www.cnbc.com time to read: 1 min

Loading chart...Boston Scientific Corp: "I've worked and seen doctors with their stuff. Loading chart...Occidental Petroleum Corp: "I'm going to say you can stick with Occidental." Loading chart...SoFi Technologies Inc: "This stock is too cheap. The CEO is going to make you money if you buy that stock at $5.36." Loading chart...Energy Transfer LP: "[Investor] Lee Cooperman said the other day that he thinks Energy Transfer is good.

☆ Mark Zuckerberg is ‘derailing’ Facebook, says Harvard expert—here's how he can get ‘back on track'
▼ + stars: | 2022-09-22 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +6 min

Mark Zuckerberg's leadership is putting Meta on track to fail, a Harvard management expert says — but it's not a lost cause. That's the suggestion for Zuckerberg from Bill George, a senior fellow at Harvard Business School and former CEO of medical technology company Medtronic. Instead, Zuckerberg has become a leader who prioritizes profits, doesn't accept advice and blames others, according to George. In February, CNBC's Jim Cramer said he has "total faith in Mark Zuckerberg" when it comes to Meta's bet on the metaverse. Why a sabbatical may be unlikely for ZuckerbergBut the odds of Zuckerberg actually following George's advice may be unlikely.

☆ FDA warns of cybersecurity risk with certain Medtronic insulin pumps
▼ + stars: | 2022-09-20 | by ( ) www.reuters.com time to read: +2 min

Register now for FREE unlimited access to Reuters.com RegisterSignage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. The agency issued a cybersecurity risk alert for the Medtronic MiniMed 600 Series insulin pump system, which has several components including an insulin pump and a blood glucose meter that communicate wirelessly. Register now for FREE unlimited access to Reuters.com RegisterThe insulin pumps are sold through Medtronic's diabetes segment, which brought in $2.41 billion in sales in 2021 and accounted for 8% of the company's total revenue. The FDA said it was working with Medtronic to identify, communicate and prevent adverse events related to this risk. Register now for FREE unlimited access to Reuters.com RegisterReporting by Mrinalika Roy in Bengaluru; Editing by Shinjini GanguliOur Standards: The Thomson Reuters Trust Principles.

☆ Cramer's lightning round: International Paper is not a buy
▼ + stars: | 2022-09-19 | by ( Krystal Hur | ) www.cnbc.com time to read: 1 min

In this article KSWKIPMDTMARAMTTRHPQLoading chart...Marathon Digital Holdings Inc: "It's just a speculative company. I just want nothing to do with it." Loading chart...International Paper Co: "Once that starts rolling over, it rolls over big. Loading chart...Stanley Black & Decker Inc: "I think that it can easily go down another 10%. If you're willing to accept that, then I think you're absolutely fine."

☆ The technology, devices, and benefits of remote patient monitoring in the healthcare industry
▼ + stars: | 2022-01-15 | by ( Shelagh Dolan | ) www.businessinsider.com time to read: +5 min

One of the tools US health systems and hospitals are turning to for improved outcomes and reduced costs is remote patient monitoring (RPM) technology. Insider IntelligenceOne of the tools US health systems and hospitals are turning to improved outcomes and reduced costs is remote patient monitoring (RPM) technology. What is remote patient monitoring (RPM)? Remote patient monitoring (RPM) is a healthcare delivery method that uses technology to monitor patient health outside of a traditional clinical setting. What are remote patient monitoring devices?

Search resuls for: "Medtronic"

16 mentions found